Anders

• Anders CPAs + Advisors (Anders), a nationally recognized CPA and business advisory firm today announced a further step in its digital transformation.
• A growing number of Anders engagement teams and clients are now being introduced to Avii , a unified practice management platform that leverages deep automation to improve the user experience for Anders clients and advisors.
• With Avii, Anders can provide efficiencies to clients and employees through a unified portal and automation platform that consolidates accounting work into one place.
• Anders’ Client Engagement Specialists (CES) are utilizing Avii to deliver a better client experience through streamlined communication and document requests.

• Nikhil Lalwani, President and CEO of ANI stated, “Strong execution has resulted in another record quarter for revenue and adjusted non-GAAP EBITDA, positioning us to raise full year 2023 guidance for the third consecutive quarter.
• Third Quarter 2023 Financial Highlights:
  Net revenues were $131.8 million compared to $83.8 million in Q3 2022.
• Since the launch of Cortrophin Gel, the overall ACTH category has experienced six consecutive quarters of year-over-year growth from second quarter 2022 to third quarter 2023.
• Sales of generic pharmaceuticals products, established brands and other grew 43.4% year-over-year in the third quarter of 2023.

• When the silent German movie Anders als die Andern (Different from the Others) premiered on May 28, 1919, in Berlin, it was an instant audience success.
• Through its public enlightenment campaign, the film made a case to abolish Paragraph 175 of the German Penal Code, which criminalized male homosexuality.

Box office hit

• The film’s box office success pleased its Austrian director, Richard Oswald.
• Anders als die Andern’s gripping story about the innocent romance between two men succumbing to anti-queer hostility served Oswald’s business model.

Queer rights and film censorship

• The institution, which was the first of its kind, became the headquarters for major scholarship on and advocacy for homosexual and trans rights.
• The latter concerns about the film indeed fed into a longstanding anti-queer trope about the threat of queer people seducing the youth into homosexuality.

Conservative pushback

• Public debates about Anders als die Andern coincided with ongoing conservative pushback against Hirschfeld’s broader work, his background as homosexual Jew, and debates about film censorship in the aftermath of World War I.
• Read more:
  The early 20th-century German trans-rights activist who transformed the world's view of gender and sexuality

  For a brief period after the war, censorship had been abolished.

Mourning with fictional characters

• However, most important for the audience appeal was the gripping melodramatic story.
• A loving relationship between two men succumbs to the effects of a blackmail campaign involving Paragraph 175.
• Based on my analyses of historical material about the reception of the film, I make a case that the film facilitates for viewers a type of mourning for the protagonist’s fate.

105th Anniversary

• The legal code would take different forms throughout the 20th century, but would not disappear from Germany’s basic law until the 1990s.
• For its 105th anniversary in 2024, viewers will be able to watch a new restoration available on DVD through the film museum in Munich, Germany.

• PROVIDENCE, R.I., Aug. 11, 2023 /PRNewswire/ -- EpiVax Inc. announces the publication of results from a research collaboration with the Food and Drug Administration aimed at streamlining generic drug evaluations.
• The results of the preclinical assessment initiative are now published in "Drug Discovery Today" titled, "Immunogenicity Risk Assessment of Synthetic Peptide Drugs and Their Impurities."
• Throughout the program, EpiVax adapted in silico and in vitro immunogenicity risk assessment methods, previously leveraged for vaccine and biologics assessment, to evaluate the immunogenicity of generic drug impurities.
• Since 2018, EpiVax's scientists have garnered extensive experience in supporting drug manufacturers with immunogenicity assessments for ANDA submissions to various global regulatory agencies.